您的购物车当前为空
别名 BEY1107, Avotaciclib
Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于研究局部晚期或转移性胰腺癌。

Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于研究局部晚期或转移性胰腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,270 | In stock | |
| 5 mg | ¥ 2,870 | In stock | |
| 10 mg | ¥ 4,250 | In stock | |
| 25 mg | ¥ 6,790 | In stock | |
| 50 mg | ¥ 9,190 | In stock | |
| 100 mg | ¥ 12,300 | In stock | |
| 500 mg | ¥ 24,800 | In stock |
Avotaciclib 相关产品
| 产品描述 | Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer. |
| 别名 | BEY1107, Avotaciclib |
| 分子量 | 281.27 |
| 分子式 | C13H11N7O |
| CAS No. | 1983983-41-0 |
| Smiles | OC1=C(N=C(C=C1)C2=NC(N)=NC=C2)C3=NC(N)=NC=C3 |
| 密度 | 1.487 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (177.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容